2014 Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Nagler A Journal Haematologica
2013 Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen: a report form the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Nagler A Journal J Clin Oncol.
2013 CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Schmidt-Hieber M Journal Blood
2013 Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission. Group Acute Leukemia Working Party (ALWP) 1st listed author Gorin NC. Journal Haematologica.
2013 Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Group Lymphoma Working Party (LWP) Acute Leukemia Working Party (ALWP) 1st listed author Roos-Weil D Journal Blood
2013 The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Giebel S Journal Bone Marrow Transplant.
2012 Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients. Group Acute Leukemia Working Party (ALWP) 1st listed author Ringdén O Journal J Intern Med.
2012 Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Schmid C Journal Blood
2012 Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Chevallier P Journal Eur J Haematol.
2012 Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Group Acute Leukemia Working Party (ALWP) Chronic Malignancies Working Party (CMWP) 1st listed author Martino R Journal Bone Marrow Transplant.
2012 Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Ringdén O Journal Br J Haematol.
2012 Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Chevallier P Journal Bone Marrow Transplant.